Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1985 2
1988 1
1990 2
1991 1
1999 1
2000 2
2001 1
2002 1
2003 1
2004 1
2005 1
2006 4
2007 1
2008 2
2009 4
2010 3
2012 2
2013 2
2014 1
2015 2
2016 6
2017 2
2018 3
2019 2
2020 7
2021 4
2022 5
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

62 results

Results by year

Filters applied: . Clear all
Page 1
(re)Producing mtEve.
DiMarco M. DiMarco M. Stud Hist Philos Biol Biomed Sci. 2020 Oct;83:101290. doi: 10.1016/j.shpsc.2020.101290. Epub 2020 Aug 13. Stud Hist Philos Biol Biomed Sci. 2020. PMID: 32800433
The Courvoisier's sign.
Giambelluca D, Dimarco M, Salvaggio G, Midiri M. Giambelluca D, et al. Among authors: dimarco m. Abdom Radiol (NY). 2019 Mar;44(3):1185-1186. doi: 10.1007/s00261-018-1881-9. Abdom Radiol (NY). 2019. PMID: 30600373 No abstract available.
Comments on: racial disparities in dermatology.
Cohen PR, DiMarco MA, Geller RL, Darrisaw LA. Cohen PR, et al. Among authors: dimarco ma. Arch Dermatol Res. 2023 Dec 16;316(1):48. doi: 10.1007/s00403-023-02798-w. Arch Dermatol Res. 2023. PMID: 38103063 No abstract available.
The "central dot sign" in acute epiploic appendagitis.
Giambelluca D, Dimarco M, Vaccaro Notte MR, Lo Re G, Midiri M. Giambelluca D, et al. Among authors: dimarco m. Abdom Radiol (NY). 2019 Apr;44(4):1606-1607. doi: 10.1007/s00261-018-1785-8. Abdom Radiol (NY). 2019. PMID: 30255443 Review. No abstract available.
Safety and efficacy of tamoxifen in boys with Duchenne muscular dystrophy (TAMDMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Henzi BC, Schmidt S, Nagy S, Rubino-Nacht D, Schaedelin S, Putananickal N, Stimpson G; North Star Consortium; Amthor H, Childs AM, Deconinck N, de Groot I, Horrocks I, Houwen-van Opstal S, Laugel V, Lopez Lobato M, Madruga Garrido M, Nascimento Osorio A, Schara-Schmidt U, Spinty S, von Moers A, Lawrence F, Hafner P, Dorchies OM, Fischer D. Henzi BC, et al. Lancet Neurol. 2023 Oct;22(10):890-899. doi: 10.1016/S1474-4422(23)00285-5. Lancet Neurol. 2023. PMID: 37739572 Clinical Trial.
62 results